Drug Approval of Aducanumab for Alzheimer’s Gets Shut Down by AdCom, Now the FDA Must Decide
A panel of experts voted against aducanumab for the treatment of Alzheimer’s disease, claiming the data does not show sufficient efficacy. Now the final decision lies in the hands of the FDA.
Technologies Making 100th Birthday A Normality
Read about the latest in aging news and the technologies being developed that could make celebrating your 100th birthday possible.
Study Shows Intermittent Fasting Did Not Reduce Weight More Than Regular Eating
Intermittent fasting has been all the rage about an easy way to lose weight. This study says otherwise.
NK Cells: Oncology’s Next Big Wave
CAR-T cells ruled the oncology field for years until their CAR-NK cell counterparts showed equivalent early efficacy without the adverse events.
NK Cells for Dummies: Understanding the Next Cancer Paradigm
Immunotherapy has been focused on T cells in the last decade. Now, there is a growing interest in NK cells. Here are the fundamentals needed to understand the approach to innate immunity.
Up to 90% of US COVID Tests Can Be False Positives
PCR testing used to classify COVID cases in the US have set their cut-off too high. This has the potential to diagnose “positive” COVID cases, even though patients may be carrying viral loads considered to be non-contagious.
COVID Cost An Estimated 160x More Than Other Pandemics
The Asian Development Bank estimates that the global impact of COVID could be $8.8 trillion, or 160x more than Ebola.
Move Along “Anti-Vaxxers”, Rushed COVID Vaccine Spurts “Vaccine-Hesitans”
There is a growing concern amid the upcoming elections and a potential vaccine being used as a political prop.
Abbott’s New $5, 15 min COVID Test A Game Changer for Symptomatic Patients
The FDA has granted authorization to a new COVID-19 test that returns results in 15 minutes and costs $5/test. It is only used to screen patients with COVID symptoms. Asymptomatic patients will not be screened with this test. The test requires a prescription and a healthcare provider to adminster it.
Touted Hangover Cure Not All It’s Made Out To Be
Study from Finland showed that L-cysteine in a supplement form was able to reduce hangover symptoms the morning after. Read the study shortcomings that place findings in doubt.
Get The Newsletter
⇒ Analysis of the latest life science news
⇒ Coverage of pharma, healthcare and biotech
⇒ Interviews and insights with industry insiders